Validation study of the OHIO chamber in patients with Japanese cedar pollinosis

International Archives of Allergy and Immunology

Volumn 149, Issue 2, 2009, Pages 141-149

  Hashiguchi, Kazuhiro ^f   Tang, Huaipeng ^a   Fujita, Toshio ^a   Suematsu, Kiyochika ^b   Tsubaki, Shigekazu ^c   Nagakura, Hitoshi ^d   Kitajima, Sei ^e   Gotoh, Minoru ^h   Okubo, Kimihiro ^g  

^a Shinryo Corporation   (Japan)

^b Chamber Business Department   (Japan)

^c Samoncho Clinic   (Japan)

^d Nagakura Allergy Clinic   (Japan)

^e Kitajima Otolaryngology Clinic   (Japan)

^f KITASATO INSTITUTE HOSPITAL   (Japan)

^g NIPPON MEDICAL SCHOOL   (Japan)

^h NIPPON MEDICAL SCHOOL CHIBA HOKUSOH HOSPITAL   (Japan)

Author keywords

Allergen exposure; Clinical trial; Japanese cedar pollen; Japanese patients; OHIO Chamber; Seasonal allergic rhinitis; Validation study

Indexed keywords

ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; JAPANESE; JAPANESE CEDAR; MALE; NOSE MUCUS; POLLEN ALLERGY; POLLEN ANALYSIS; PRESSURE CHAMBER; PRIORITY JOURNAL; REPRODUCIBILITY; SNEEZING; SUMMER; SYMPTOMATOLOGY; VALIDATION STUDY; WINTER;

ADULT; ALLERGENS; ATMOSPHERE EXPOSURE CHAMBERS; CROSS-OVER STUDIES; CRYPTOMERIA; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INHALATION EXPOSURE; MALE; MIDDLE AGED; POLLEN; REPRODUCIBILITY OF RESULTS; RHINITIS, ALLERGIC, SEASONAL;

EID: 58149173218     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000189197     Document Type: Article

References (19)

1. Okuda M: Epidemiology of Japanese cedar pollinosis throughout Japan. Ann Allergy Asthma Immunol 2003; 91:288-296.
2. Okubo K, Gotoh M, Shimada K, Ritsu M, Okuda M, Crawford B: Fexofenadine improves the quality of life and work productivity in Japanese patients with seasonal allergic rhinitis during the peak cedar pollinosis season. Int Arch Allergy Immunol 2005; 136: 148-154.
3. Okuda M, Fukaya S, Kobayashi K, Itou Y, Zeze H, Shidara T, et al: Effects of emedas-tine on Japanese cedar pollinosis. A multi-centered, double-blind study (in Japanese). Pract Otorhinolaryngol 1995; 88: 797-816.
4. Imanaka M, Terada T, Takenaka H, Dejima K, Kawata R, Takagi N, Saitou K, Murakami Y, Fujieda S, Noda I, Saitou H: Evaluation of initial treatment with IPD on Japanese cedar pollinosis-trial at the same time in three different regional facilities (in Japanese). Jpn J Rhinol 1998; 37:316-322.
5. Ohta N, Inakura K, Noda D, G on S , Ishida A: The effect of prophylactic treatment wit be-potastine in patients wit Japanese cedar pollinosis (in Japanese). Pract Otorhinolaryngol 2002; 95: 531-537.
6. Horak F, Stübner UP, Zieglmayer R, Harris AG: Effect of desloratadine versus placebo on nasal airflow and subjective measures of nasal obstruction in subjects with grass pollen-induced allergic rhinitis in an allergen-exposure unit. J Allergy Clin Immunol 2002; 109:956-961.
7. Day JH, Briscoe MP, Rafeiro E, Chapman D, Kramer B: Comparative onset of action and symptom relief with cetirizine, loratadine, or placebo in an environmental exposure unit in subjects with seasonal allergic rhinitis: confirmation of a test system. Ann Al-lerg y Ast hma Immunol 2001; 87: 474-481.
8. Patel D, Garadi R, Brubaker M, Conroy PJ, Kaji Y, Crenshaw K, Whitling A, Wall GM: Onset and duration of action of nasal sprays in seasonal allergic rhinitis patients: olopata-dine hydrochloride versus mometasone fu-roate monohydrate. Allergy Asthma Proc 2007; 28:592-599.
9. Krug N, Loedding H, Hohlfeld JM, Larbig M, Buckendahl A, Badorrek P, Geldmacher H, Behnke W, Dunkhorst W, Windt H, Luettig B, Koch W: Validation of an environmental exposure unit for controlled human inhalation studies with grass pollen in patients with seasonal allergic rhinitis. Clin Exp Al-lerg y 2003; 33: 1667-1674.
10. Berkowitz RB, Woodworth GG, Lutz C, Wei-ler K, Weiler J, Moss M, Meeves S: Onset of action, efficacy, and safety of fexofenadine 60 mg/pseudoephedrine 120 mg versus placebo in the Atlanta allergen exposure unit. Ann Allergy Asthma Immunol 2002; 89:38-45.
11. Hashiguchi K, Tang H, Fujita T, Tsubaki S, Fujita M, Suematsu K, Gotoh M, Okubo K: Preliminary study on Japanese cedar pollinosis in an artificial exposure chamber (OHIO Chamber). Allergol Int 2007; 56:125-130.
12. Enomoto T, Ide T, Ogino S: Construction of an environmental exposure unit and investigation of the effects of cetirizine hydrochlo-ride on symptoms of cedar pollinosis in Japan. J Investig Allergol Clin Immunol 2007; 17:173-181.
13. Yuki A, Hyo S, Higashino M, Terada T, Tak-enaka H: A study of Japanese cedar pollino-sis using an environmental exposure unit (in Japanese). J Jpn Immunol Allergol Otolaryn-gol 2006; 24: 77-78.
14. Day JH, Horak F, Briscoe MP, Canonica GW, Fineman SM, Krug N, Leynadier F, Lieber-man P, Quirce S, Takenaka H, Van Cauwen-berge P: The role of allergen challenge chambers in the evaluation of anti-allergic medication: an international consensus paper. Clin Exp Allergy Rev 2006; 6:31-59.
15. Naclerio RM, Proud D, Kagey-Sobotka A, Lichtenstein LM, Thompson M, Togias A: Cold dry air-induced rhinitis: effect of inhalation and exhalation through the nose. J Appl Physiol 1995; 79: 467-471.
16. Stuebner P, Horak F, Zieglmayer R, Ar náiz E , Leuratti C, Pérez I, Izquierdo I: Effects of ru-patadine vs placebo on allergen-induced symptoms in patients exposed to aeroaller-gens in the Vienna Challenge Chamber. Ann Allergy Asthma Immunol 2006; 96:37-44.
17. Krug N, Hohlfeld JM, Geldmacher H, Larbig M, Heermann R, LaVallee N, Nguyen DT, Petzold U, Hermann R: Effect of loteprednol etabonate nasal spray suspension on seasonal allergic rhinitis assessed by allergen challenge in an environmental exposure unit. A llerg y 2005; 60: 354-359.
18. Bousquet J, Van Cauwenberge P, Khaltaev N: Aria Workshop Group. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108(suppl 5):S147-S334.
19. Horak F, Toth J, Marks B, Stübner UP, Berger UE, Jäger S, Burtin B, Duby C: Efficacy and safety relative to placebo of an oral formulation of cetirizine and sustained-release pseudoephedrine in the management of nasal congestion. Allergy 1998; 53:849-856.